Article info

Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population

Authors

  1. Correspondence to Professor Hironori Sagara; sagarah{at}med.showa-u.ac.jp
View Full Text

Citation

Sagara H, Barbier N, Ishii T, et al
Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population

Publication history

  • Received December 7, 2020
  • Revised January 11, 2021
  • Accepted January 16, 2021
  • First published March 18, 2021.
Online issue publication 
March 18, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.